These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32226827)

  • 1. Effects of treatment interruption due to patient convenience on treatment of once a week teriparatide.
    Katahira G; Akiba K; Takada J; Iba K; Yamashita T
    Osteoporos Sarcopenia; 2020 Mar; 6(1):8-14. PubMed ID: 32226827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different parameters between daily and twice-weekly teriparatide in postmenopausal women with severe osteoporosis.
    Mochizuki T; Yano K; Ikari K; Okazaki K
    J Bone Miner Metab; 2023 Mar; 41(2):220-226. PubMed ID: 36625920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of switching once-weekly teriparatide to denosumab in osteoporosis patients.
    Miyagi M; Fujimaki H; Naruse K; Suto K; Inoue G; Nakazawa T; Imura T; Saito W; Uchida K; Shirasawa E; Takahira N; Takaso M
    J Orthop Sci; 2019 Jan; 24(1):153-158. PubMed ID: 30146385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of once-weekly and twice-weekly injections of teriparatide by patient characteristics: A post hoc analysis of the TWICE study.
    Sugimoto T; Yoshimura T; Uzawa T
    Osteoporos Sarcopenia; 2021 Mar; 7(1):11-16. PubMed ID: 33869800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twice-weekly teriparatide improves lumbar spine BMD independent of pre-treatment BMD and bone turnover marker levels.
    Takada J; Yoshimura T; Uzawa T
    J Bone Miner Metab; 2021 May; 39(3):484-493. PubMed ID: 33389132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Density After Teriparatide Discontinuation With or Without Antiresorptive Therapy in Pregnancy- and Lactation-Associated Osteoporosis.
    Lee S; Hong N; Kim KJ; Park CH; Lee J; Rhee Y
    Calcif Tissue Int; 2021 Nov; 109(5):544-553. PubMed ID: 34037833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.
    Anastasilakis AD; Polyzos SA; Avramidis A; Papatheodorou A; Terpos E
    Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of patient background factors on the treatment efficacy of once-weekly teriparatide.
    Omura F
    Osteoporos Sarcopenia; 2019 Jun; 5(2):51-56. PubMed ID: 31338435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis.
    Cosman F; Nieves JW; Dempster DW
    J Bone Miner Res; 2017 Feb; 32(2):198-202. PubMed ID: 27925287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats.
    Shimizu T; Tanaka T; Kobayashi T; Kudo I; Nakatsugawa M; Takakura A; Takao-Kawabata R; Ishizuya T
    Bone Rep; 2017 Dec; 7():70-82. PubMed ID: 28948197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Teriparatide and Sequential Minodronate on Lumbar Spine Bone Mineral Density and Microarchitecture in Osteoporosis.
    Miyaoka D; Imanishi Y; Ohara M; Hayashi N; Nagata Y; Yamada S; Mori K; Emoto M; Inaba M
    Calcif Tissue Int; 2017 Oct; 101(4):396-403. PubMed ID: 28589205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlapping and continued alendronate or raloxifene administration in patients on teriparatide: effects on areal and volumetric bone mineral density--the CONFORS Study.
    Muschitz C; Kocijan R; Fahrleitner-Pammer A; Pavo I; Haschka J; Schima W; Kapiotis S; Resch H
    J Bone Miner Res; 2014 Aug; 29(8):1777-85. PubMed ID: 24619763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Phosphate Reabsorption is Correlated with the Increase in Lumbar Bone Mineral Density in Patients Receiving Once-Weekly Teriparatide.
    Takeuchi Y; Kuroda T; Sugimoto T; Shiraki M; Nakamura T
    Calcif Tissue Int; 2016 Feb; 98(2):186-92. PubMed ID: 26478225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral density.
    Muschitz C; Kocijan R; Fahrleitner-Pammer A; Lung S; Resch H
    J Bone Miner Res; 2013 Jan; 28(1):196-205. PubMed ID: 22836585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate.
    Yano T; Yamada M; Inoue D
    Calcif Tissue Int; 2017 Jul; 101(1):102-110. PubMed ID: 28337514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates.
    Seno T; Yamamoto A; Kukida Y; Hirano A; Kida T; Nakabayashi A; Fujioka K; Nagahara H; Fujii W; Murakami K; Oda R; Fujiwara H; Kohno M; Kawahito Y
    Springerplus; 2016; 5(1):1056. PubMed ID: 27462504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Different Perspectives of Drug Holiday and Combination Therapies When Treating Osteoporosis].
    Oser S; Häuselmann HJ
    Praxis (Bern 1994); 2021; 110(16):975-983. PubMed ID: 34875857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of sequential therapy from short-term teriparatide to denosumab compared with denosumab alone in patients with osteoporotic hip fracture: a 1-year follow-up study.
    Park CH; Yoo JI; Choi CH; Suh YS
    BMC Musculoskelet Disord; 2020 Nov; 21(1):751. PubMed ID: 33189148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of osteoporotic treatment in patients with new spinal vertebral compression fracture pain, ADL, QOL, bone metabolism and fracture-healing - In comparison with weekly teriparatide with bisphosphonate.
    Shigenobu K; Hashimoto T; Kanayama M; Ohha H; Yamane S
    Bone Rep; 2019 Dec; 11():100217. PubMed ID: 31440529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic and antiresorptive therapy for osteoporosis: combination and sequential approaches.
    Cosman F
    Curr Osteoporos Rep; 2014 Dec; 12(4):385-95. PubMed ID: 25341476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.